VEE 2023: Corneal cross-linking in the 21st century
Mitch Ibach, OD, FAOO, tells us about the current corneal cross-linking treatments, as well as those on the horizon.
VEE 2023: Legal perspective on keratoconus management
Katie Gilbert-Spear, OD, MPH, gives an overview on the importance of referring keratoconus patients to receive FDA-approved corneal cross-linking.
World Optometry Day 2023: What does optometry mean to you?
On World Optometry Day 2023, we asked experts to share what this industry means to them.
Enrollment complete for BRIO-I Phase 2 clinical trial of Brimochol PF for presbyopia
Following the enrollment completion for Brimochol PF, topline Phase 3 data for the presbyopia candidate is expected in Q2 2023.
VEE 2023: Hear what's new with Lumenis
Catch up on what to expect from Lumenis.
VEE 2023: Find out what's hot in retina with Dr. Mo
Mohammad Rafieetary, OD, shares key highlights from his VEE 2023 presentation looking at what's hot in retina.
Vision Expo East 2023 preview: An agenda jam-packed with education, frame sales, and practice management tips
Vision Expo East 2023 will take place in New York, New York, on March 16-19 at the Javits Center.
Optical Lab Software Solutions becomes Rx-Universe in global rebranding
To maintain brand recognition, Optical Lab Software and Solutions is now Rx-Universe’s brand statement, which clearly communicates what the organization offers.
SECO 2023: Sleep disorders impact eye disease
Paul Chous, MA, OD, FAAO, shares key highlights from his 2023 SECO presentation looking at sleep disorders and how they play a role in eye disease.
The future of optometry shines brightly at OIS @ SECO Innovation Showcase
In Atlanta, Georgia, the OIS @ SECO Innovation Showcase highlighted the best and the brightest optometric and ophthalmic drugs, therapies, and tech we hope to see come to fruition.
SECO 2023: Neuro nuggets with Dr Lee
Andy Lee, MD, gives highlights from his SECO special session, "Neuro nuggets."
SECO 2023: Glaucoma treatments in the optometrist's wheelhouse
Nate Lighthizer, OD, gives highlights from his SECO 2023 presentation, "The glaucoma compass."
SECO 2023: Pipeline update from Tarsus
Tarsus has received a PDUFA date for their TP-03 drug, which they are hoping to bring to market later this year.
Pharmedica USA Purely Soothing 15% MSM eye drops recalled due to non-sterility
Contaminated Purely Soothing 15% MSM drops carry risk of eye infections that may result in vision loss. All consumers should stop use immediately.
SECO 2023: Learning about the lids
Mile Brujic, OD, shares highlights from his SECO 2023 presentation, "Learning about the Lid: Optimizing recognition, diagnosis, and treatment of Demodex blepharitis and blepharoptosis."
SECO 2023: Incorporating confocal scanning laser imaging in practice
Mile Brujic, OD, shares highlights from his SECO 2023 poster presentation on confocal scanning laser imaging and patient care.
SECO 2023: Hot news or not news?
Chris Wroten, OD, shares key takeaways from his "Hot news or not news?" presentation at SECO 2023.
SECO 2023: Lasers in optometry: The next frontier
Nate Lighthizer, OD, shares what to expect from his SECO workshop, "Lasers in Optometry: The Next Frontier."
SECO 2023: Orasis Pharmaceuticals presents pipeline update at OIS
Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.
SECO 2023: Keeping an eye on geographic atrophy
Mohammed Rafieetary, OD, shares key takeaways from his SECO 2023 presentation, "Advancing the understanding of geographic atrophy."
SECO 2023: Caring for myopic patients through lifestyle interventions
Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO, shares key takeaways from her SECO 2023 panel discussion, "Myopia management."
SECO 2023: Diabetes then and now
Paul Chous, MA, OD, FAAO, gives key takeaways from his 2023 SECO presentation on diabetes: then and now.
SECO 2023: Laser workshop for optometrists
Chris Wroten, OD, shares highlights from the hands-on laser workshop he co-led during SECO 2023.
SECO 2023: Drugs of the future
Milton M. Hom, OD, FAAO, FACAAI (Sc), shares key takeaways from his SECO 2023 presentation, "Drugs of the future."
SECO 2023: Valuing your contact lens patients, while valuing yourself
Shalu Pal, BSc, OD, FAAO, shares key takeaways from the contact lens zpanel discussion she participated in.
SECO 2023: Contact lenses for presbyopic patients
Milton M. Hom, OD, FAAO, FACAAI (Sc), shares key highlights from his portion of the "Presbyopia management panel," during SECO 2023 in Atlanta.
First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease
BRIM Biotechnology’s BRM421 is a first-in-class regenerative peptide and could relieve signs and symptoms of dry eye disease in as little as 2 weeks.
CooperVision’s MyDays Energys contact lenses hit US market
First 1-Day Lens that combines DigitalBoost and Aquaform technologies
designed to deliver comfort for ‘always on’ digital lifestyles
IKA Keratoconus Symposium 2023: Live patient Q&A, in-person white paper development, and more
Andrew Morgenstern, OD, FAAO, FNAP, sits down to discuss the inaugural IKA Keratoconus Symposium in Scottsdale, Arizona, in April 2023.
Orasis Pharmaceuticals’ NDA for CSF-1 for presbyopia accepted by FDA
A PDUFA goal date of October 22, 2023 was assigned to the investigational eye drop candidate for the treatment of presbyopia.
2 Clarke Drive Cranbury, NJ 08512